These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Radiotherapy in supratentorial low grade gliomas]. Mascarenhas F; Matos JA; Ortiz M; Pires MF; Grillo IM Acta Med Port; 2002; 15(6):451-9. PubMed ID: 12680293 [TBL] [Abstract][Full Text] [Related]
4. Radiotherapy in supratentorial gliomas. A study of 821 cases. Heesters M; Molenaar W; Go GK Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126 [TBL] [Abstract][Full Text] [Related]
5. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880 [TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas. Yeh SA; Ho JT; Lui CC; Huang YJ; Hsiung CY; Huang EY Br J Radiol; 2005 Mar; 78(927):230-5. PubMed ID: 15730987 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients. Ahmadi R; Dictus C; Hartmann C; Zürn O; Edler L; Hartmann M; Combs S; Herold-Mende C; Wirtz CR; Unterberg A Acta Neurochir (Wien); 2009 Nov; 151(11):1359-65. PubMed ID: 19575144 [TBL] [Abstract][Full Text] [Related]
9. The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas. Yamaguchi S; Kobayashi H; Terasaka S; Ishii N; Ikeda J; Kanno H; Nishihara H; Tanaka S; Houkin K Jpn J Clin Oncol; 2012 Apr; 42(4):270-7. PubMed ID: 22399670 [TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy. Mariani L; Deiana G; Vassella E; Fathi AR; Murtin C; Arnold M; Vajtai I; Weis J; Siegenthaler P; Schobesberger M; Reinert MM J Clin Oncol; 2006 Oct; 24(29):4758-63. PubMed ID: 16966689 [TBL] [Abstract][Full Text] [Related]
11. Neuropathological and molecular aspects of low-grade and high-grade gliomas. Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604 [TBL] [Abstract][Full Text] [Related]
12. Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component. Walker C; du Plessis DG; Fildes D; Haylock B; Husband D; Jenkinson MD; Joyce KA; Broome J; Kopitski K; Prosser J; Smith T; Vinjamuri S; Warnke PC Clin Cancer Res; 2004 Nov; 10(21):7182-91. PubMed ID: 15534091 [TBL] [Abstract][Full Text] [Related]
13. Impact of intraoperative MRI on the surgical results for high-grade gliomas. Hirschberg H; Samset E; Hol PK; Tillung T; Lote K Minim Invasive Neurosurg; 2005 Apr; 48(2):77-84. PubMed ID: 15906201 [TBL] [Abstract][Full Text] [Related]
14. [Significance of stereotactic biopsy for the management of WHO grade II supratentorial glioma]. Muacevic A; Kreth FW Nervenarzt; 2003 Apr; 74(4):350-4. PubMed ID: 12707704 [TBL] [Abstract][Full Text] [Related]
15. [Individualized treatment strategies in adults with supratentorial WHO grade II gliomas]. Kreth FW; Peraud A; Tonn JC MMW Fortschr Med; 2004 Apr; 146(14):26-8. PubMed ID: 15344747 [No Abstract] [Full Text] [Related]
16. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
17. [Delayed surgical operations in benign supratentorial gliomas]. Kravets LIa; Trofimov AO Zh Vopr Neirokhir Im N N Burdenko; 2009; (1):24-8. PubMed ID: 19505027 [TBL] [Abstract][Full Text] [Related]
18. Immediate postoperative radiotherapy or "watch and wait" in the management of adult low-grade glioma? Kortmann RD; Jeremic B; Weller M; Lutterbach J; Paulsen F; Bamberg M Strahlenther Onkol; 2004 Jul; 180(7):408-18. PubMed ID: 15241528 [TBL] [Abstract][Full Text] [Related]
19. Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. Kiwit JC; Floeth FW; Bock WJ Zentralbl Neurochir; 1996; 57(2):76-88. PubMed ID: 8779273 [TBL] [Abstract][Full Text] [Related]
20. Objective response to radiation therapy and long-term survival of patients with WHO grade II astrocytic gliomas with known LOH 1p/19q status. Fathi AR; Vassella E; Arnold M; Curschmann J; Reinert M; Vajtai I; Weis J; Deiana G; Mariani L Strahlenther Onkol; 2007 Sep; 183(9):517-22. PubMed ID: 17762927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]